| Active Ingredient | METFORMIN |
| Therapeutic Class | BIGUANIDES |
| Indications |
Diabetes mellitus in obese, mature onset, diabetes without ketosis, when diet and attempts at weight loss fail. |
| Caution |
Anorexia or dyspep sia occurs in 15% of cases. Lactic acidosis is an infrequent side effect. Nausea, vomiting, diarrhoea, flatulence. C.f. Prescribing in liver and renal disease p. 15; 32. Not recom More ... |
| Dose Range |
500mg 2-3 times daily or 850mg once or twice daily with or after meals. Gradually increase at intervals of at least 1 week, to 2- 3 g daily . Doses greater than 2g, give in 3 divided doses. Extended Release: Initial dose of 500 mg once daily in |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | METFORMIN XR |
| Therapeutic Class | BIGUANIDES |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |